The short version of 方法验证 fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-02-16 and is reviewed periodically as new material appears.
Published work supports the view that engaging two incretin receptors produces changes in glucose handling and body weight larger than those seen with single-receptor activation. Why that difference arises is not fully settled. Open questions include how much of the observed weight effect depends on central versus peripheral signaling, and whether the two receptors form interacting complexes. Most reported findings come from controlled trials and animal models, and translation between species is imperfect. Further research is expected to refine these points over time.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its sequence is related to human glucose-dependent insulinotropic polypeptide, with modifications that include a C-terminal extension and a C20 fatty diacid joined through a linker. Those changes raise the molecule's affinity for serum albumin, which slows renal filtration and lengthens the time it stays in circulation. The free base has an average molecular mass near 4813.5 daltons. The compound is made by solid-phase peptide synthesis followed by chromatographic purification.
At the receptor level, tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Both belong to the class B family of G protein-coupled receptors and signal largely through cyclic AMP accumulation. The compound binds the two receptors with differing affinity, and the pattern of signaling at each site is described in the literature as biased rather than simply proportional to occupancy. Tissues carrying these receptors include pancreatic islets, adipose tissue, the central nervous system, and the gastrointestinal tract. The relative weight of each receptor population in producing metabolic effects continues to be studied.
Regulatory and quality discussions place the peptide within established guidance for synthetic peptides and biologics. Forced degradation studies, in which samples are exposed to heat, acid, base, peroxide, and light, identify likely degradation products and validate the selectivity of analytical methods. Reference standards allow comparison across laboratories and production batches. Purity specifications reported in the literature usually combine chromatographic purity with mass confirmation. Which impurity thresholds are meaningful for long-term behavior is still debated, and no single universal specification has been adopted across all jurisdictions.
Routine characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity assessment, usually with ultraviolet detection near 214 nanometers. Intact mass measurement by liquid chromatography coupled to mass spectrometry confirms molecular identity against a theoretical value. Sequence-level confirmation uses enzymatic digestion followed by tandem mass spectrometry, an approach known as peptide mapping. Amino acid analysis gives an independent check on composition. Circular dichroism spectra are used to estimate helical content in aqueous buffer.
Stability depends strongly on physical form. The dry powder is generally regarded as stable for extended periods when held at or below minus twenty degrees Celsius in a sealed, desiccated container. In solution, degradation pathways include deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation. Reaction rates for these pathways rise with temperature. Repeated freezing and thawing of solutions promotes aggregation, and light exposure can accelerate some oxidative changes. Buffer composition and pH influence which pathway dominates at a given temperature.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | 39-residue synthetic peptide |
| Average molecular mass | About 4813.5 Da | Free base form |
| Appearance | White to off-white powder | Solid after lyophilization |
| Solubility class | Freely soluble in water | Also soluble in neutral aqueous buffers |
| Typical storage | At or below -20 °C, desiccated | Protect from light and moisture |
Tirzepatide 是一种由 39 个氨基酸组成的合成肽，分子结构上以 GIP 序列为骨架并引入脂肪酸侧链修饰，使其能够同时与葡萄糖依赖性促胰岛素多肽（GIP）受体和胰高血糖素样肽-1（GLP-1）受体结合。这种双重激动特性使它在同类肽类药物中区别于选择性 GLP-1 受体激动剂。该分子最早由一家制药公司在 2010 年代报道，随后进入糖尿病与体重管理领域的临床研究。
在生理层面，GIP 与 GLP-1 均为肠道内分泌细胞分泌的肠促胰素，进食后参与胰岛素分泌调节与胃排空抑制。Tirzepatide 通过同时激活这两条信号通路，使胰岛素分泌的葡萄糖依赖性增强，并延缓冲胃排空、降低食欲信号。与单一 GLP-1 激动相比，双靶点作用在血糖控制和体重变化上的效应幅度更大，但具体贡献比例仍在研究之中。
脂肪酸侧链的存在使该肽与血浆白蛋白结合能力增强，从而延长循环半衰期，支持每周一次给药的用药间隔。白蛋白结合同时改变组织分布特征，减慢肾脏清除速度。该设计思路在多种长效肽类药物中被反复采用，属于既定的药代动力学策略。
定量分析的主流方法是反相高效液相色谱联用紫外或质谱检测，利用肽在疏水固定相上的保留行为确定纯度与含量。对于生物基质中的浓度测定，常采用液相色谱串联质谱，并配合固相萃取或蛋白沉淀进行样品前处理。免疫分析法也可使用，但可能受到结构相关肽的交叉反应干扰。
纯度评估通常综合反相色谱、体积排阻色谱与质谱三方面信息：前者反映疏水性杂质，后者反映聚集体，质谱则确认分子量与主要降解产物。有关降解途径的完整图谱——例如脱酰胺、氧化与水解各占多大比例——在不同储存条件下仍有差异，属于需要逐案验证的问题。
质量控制环节关注外观、含量、纯度、有关物质、水分与微生物限度等项目。检测结果需要有对照品和系统适用性数据支持，单次测定不足以判定批次的稳定性。实验室之间方法转移时，色谱柱品牌与梯度差异常导致保留时间漂移，因此方法验证十分必要。
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
Peptide active ingredients of this type are typically supplied as lyophilized powder because the dry form resists hydrolysis during transport. The material is hygroscopic, so vials are usually equilibrated to room temperature before opening to avoid condensation on the solid. Repeated freeze-thaw cycles can promote aggregation and are generally avoided by aliquoting stock into single-use portions. Personnel handling the powder work in controlled environments to limit inhalation of fine particles. Written procedures usually specify these steps rather than leaving them to individual judgment.
Long-term storage of the solid generally relies on temperatures at or below minus twenty degrees Celsius, while short-term working stocks may be held refrigerated. Light exposure is limited because photodegradation can alter side chains over extended periods. Solutions prepared for analysis are less stable than the dry powder and are typically used within the same working day. Buffer choice matters, since some aqueous conditions favor deamidation or oxidation at specific residues. Stability data are usually generated under defined accelerated conditions and then extrapolated with stated assumptions.
1946 in Cairo), historian, academic, scholar, author of over fifteen books, essayist, Emeritus Professor of Comparative European History at Queen Mary, University of London . George Sassoon (30 October 1936 – 8 March 2006), British scientist, electronic engineer, linguist, translator and science fiction author of Iraqi Jewish Mizrahi Jewish origin; author of The Manna-Machine (1978) and The Kabbalah Decoded (1978). Siegfried Sassoon, writer and WW1 poet, of Iraqi Jewish Mizrahi Jewish origin. Charles Saatchi (Arabic: تشارلز ساعتجي; born 9 June 1943); author of numerous books, periodicals, journals and monographs on art and culture, Mizrahi Jewish Iraqi-Jewish British businessman and co-founder, with brother Maurice, of advertising agency Saatchi & Saatchi, the world's largest advertising agency; later formed a new agency called M&C Saatchi; also known for his art collection and for owning Saatchi Gallery, and for sponsorship of the Young British Artists (YBAs), including Damien Hirst and Tracey Emin.Successful campaigns included Silk Cut's advertisements and those for Conservative Party's 1979 general election victory – led by Margaret Thatcher through the slogan "Labour Isn't Working". Other clients included British Airways. In the Sunday Times Rich List 2009 ranking of the wealthiest people in the UK, was grouped with brother Maurice, with estimated fortune of £120 million.
== Early life == Markin was born and raised in Lincoln, Nebraska. He received a Bachelor of Science degree in 1977 from Nebraska Wesleyan University, where he majored in chemistry with minors in mathematics and physics. He received a Ph.D. in chemistry from the University of Nebraska–Lincoln in 1980; he earned his medical degree from the University of Nebraska Medical Center (UNMC) in 1983; he completed his residency in pathology and laboratory medicine at UNMC in 1986. He has been on the UNMC faculty since 1986. His professional and academic research interests have focused on clinical laboratory automation including robotics, information systems, medical utilization management, business efficiency modeling, adult and pediatric pathology, liver/gastrointestinal pathology, telehealth, telemedicine, technology development and mobile health.
== Biosynthesis == α-Amanitin and other amatoxins are synthesized on ribosomes and modified by several tailoring enzymes. The ribosomally synthesized peptide, called the precursor peptide, is recognized by a Prolyl Oligopeptidase B (POPB) enzyme. POPB cleaves the precursor peptide and cyclizes the remaining octapeptide. Following cyclization, the peptide is hydroxylated by P450-29 and FMO1 enzymes. The hydroxylations of isoleucine and tryptophan contribute to the high-affinity binding of α-amanitin to RNA polymerase II. Unknown enzyme machinery installs the tryptathionine bridge.
Opium production has led to rising tensions in Afghan villages. Though direct conflict has yet to occur, the opinions of the new class of young rich men involved in the opium trade are at odds with those of the traditional village leaders.
Food and Drug Administration (FDA) was a Zydis ODT formation of Claritin (loratadine) in December 1996. It was followed by a Zydis ODT formulation of Klonopin (clonazepam) in December 1997, and a Zydis ODT formulation of Maxalt (rizatriptan) in June 1998. The regulatory condition for meeting the definition of an orally disintegrating tablet is USP method 701 for Disintegration. FDA guidance issued in Dec 2008 is that ODT drugs should disintegrate in less than 30 seconds. This practice is under review by the FDA as the fast disintegration time of ODTs makes the disintegration test too rigorous for some of the ODT formulations that are commercially available.
Sources: en.wikipedia.org
== Genomics == The human OTC gene is located on the short arm of chromosome X (Xp21.1). The gene is located in the Watson (plus) strand and is 73 kbases in length. The open reading frame of 1,062 nucleotides is disbursed between 10 exons and nine introns. The encoded protein is 354 amino acids long with a predicted molecular weight of 39.935 kD. Postranscriptional modification leaves the mature peptide with 322 amino acids and a weight of 36.1 kD. The protein is located in the mitochondrial matrix. In mammals, OTC is expressed in the liver and small intestinal mucosa.
The Flow of Dry Water - The Feynman Lectures on Physics Science 101 Q: Is It Really Caused by the Bernoulli Effect? Millersville University – Applications of Euler's equation NASA – Beginner's guide to aerodynamics Archived 2012-07-15 at the Wayback Machine Misinterpretations of Bernoulli's equation – Weltner and Ingelman-Sundberg Archived 2012-02-08 at the Wayback Machine
Andean textiles Chakitaqlla Chinchaypujio District Chuspas Indigenous peoples in Argentina Indigenous peoples in Bolivia Indigenous peoples in Ecuador Indigenous peoples of Peru Inkarrí Kichwa Quechuan languages Secret of the Incas, movie with conversation and singing in Quechua Sumak kawsay Yanantin
== External links == Insulin Pump Terminology: Basal Rates Information on the varying basal rate needs throughout the day General guidelines on changing basal rate Further guidelines in changing basal rate
=== Reducing end === Disaccharides consist of two monosaccharides and may be either reducing or nonreducing. Even a reducing disaccharide will only have one reducing end, as disaccharides are held together by glycosidic bonds, which consist of at least one anomeric carbon. With one anomeric carbon unable to convert to the open-chain form, only the free anomeric carbon is available to reduce another compound, and it is called the reducing end of the disaccharide. A nonreducing disaccharide is that which has both anomeric carbons tied up in the glycosidic bond. Similarly, most polysaccharides have only one reducing end.
Sources: en.wikipedia.org
== Towards Seismic Cloaking == Computations showed that seismic waves traveling toward a building, could be directed around the building, leaving the building unscathed, by using seismic metamaterials. The very long wavelengths of earthquake waves would be shortened as they interact with the metamaterials; the waves would pass around the building so as to arrive in phase as the earthquake wave proceeded, as if the building was not there. The mathematical models produce the regular pattern provided by metamaterial cloaking. This method was first understood with electromagnetic cloaking metamaterials—the electromagnetic energy is in effect directed around an object, or hole, and protecting buildings from seismic waves employs this same principle. Giant polymer-made split-ring resonators combined with other metamaterials are designed to couple at the seismic wavelength. Concentric layers of this material would be stacked, each layer separated by an elastic medium. The design that worked is ten layers of six different materials, which can be easily deployed in building foundations. As of 2009, the project is still in the design stage. In 2019, scientists identified flaws in models of seismic cloaks related to extrapolations from photonics, and proved that a perfect cloak, which bends out-of-plane waves completely away from a structure, is not feasible (though they can be dampened), but a cloak which protects against surface waves and dampens others is still possible.
=== Blood reservoir === Because the liver is an expandable organ, large quantities of blood can be stored in its blood vessels. Its normal blood volume, including both that in the hepatic veins and that in the hepatic sinuses, is about 450 milliliters, or almost 10 percent of the body's total blood volume. When high pressure in the right atrium causes backpressure in the liver, the liver expands, and 0.5 to 1 liter of extra blood is occasionally stored in the hepatic veins and sinuses. This occurs especially in cardiac failure with peripheral congestion. Thus, in effect, the liver is a large, expandable, venous organ capable of acting as a valuable blood reservoir in times of excess blood volume and capable of supplying extra blood in times of diminished blood volume.
precipitate 1. (n.) A solid substance that separates from a liquid solution or diffuses out of a solid alloy during the process of precipitation. 2. (v.) To separate from another substance by forming a distinct, condensed solid phase.
=== mEos2 === mEosFP is another monomeric Eos variant that folds effectively at 37 degrees Celsius. Where tdEos (tandem dimer) cannot fuse to targets such as histones, tubulin, intermediate filaments and gap junctions, and mEos (monomeric) which can only be used successfully at 30 degrees Celsius, mEos2 is an engineered variant that can fold effectively at 37 degrees Celsius and successfully label targets intolerant to fusion from other fluorescent protein dimers . mEos2 shows almost identical spectral properties, brightness, pKa, photoconversion, contrast and maturation properties to WT Eos. The localization precision of mEos2 is twice as great as other monomeric fluorescent proteins.
== See also == Lists of investigational drugs List of investigational generalized anxiety disorder drugs List of investigational social anxiety disorder drugs List of investigational panic disorder drugs List of investigational post-traumatic stress disorder drugs
Sources: en.wikipedia.org
It is a synthetic peptide and a dual agonist of two incretin receptors. It is not a small molecule, and it is not structurally related to the older single-receptor peptide agonists.
The C20 fatty diacid promotes tight binding to serum albumin. That binding reduces renal clearance and extends circulation time compared with an unmodified peptide of similar length.
It is not fully established. Studies indicate that both receptors contribute to the observed effects, but the exact split between the two signaling pathways in humans remains an open question.
Peptide mapping with tandem mass spectrometry is the standard approach. The peptide is digested with an enzyme such as trypsin, and the resulting fragments are matched against the expected sequence.